DNAprint Genomics (DNAG)

[mingwan0]

W2P, we both know that the use of subjective racial categories as per the initial guidelines will almost certainly be mandated by the FDA. We also both know that this will result in scientific data that is effectively worthless for ascertaining population structure based influences on clinical trial results. It would be nice to see the FDA do the right thing, but I suspect that "political" considerations will militate against this.